For a lot of people in buprenorphine treatment, taking a daily sublingual film or tablet (like Suboxone) works well and becomes a simple, reliable part of the routine. If that's you, there's no need to change anything. But daily dosing isn't the only FDA-approved way to take buprenorphine, and it isn't the best fit for everyone. Extended-release injectable buprenorphine — brand names Sublocade and Brixadi — is worth understanding as an option, so you can talk with your provider about whether it might make sense for your situation.
Freedom from Daily Dosing
Daily medication means daily remembering — and life doesn't always cooperate with that. Irregular work schedules, frequent travel, caregiving responsibilities, or simply a history of finding it hard to stick with a daily routine can all make once-a-day dosing more stressful than it needs to be. With an extended-release injection, the medication is administered by your provider on a set schedule — weekly with Brixadi, or monthly with either Sublocade or Brixadi — so you're not relying on remembering a dose every single day. For many patients, that alone is a meaningful reduction in daily mental load.
No Diversion Risk
Because the injection is given directly by a healthcare provider in the clinic, there's no take-home medication to store, secure, or keep track of. That removes any chance of the medication being misplaced, shared with someone else, taken incorrectly, or accidentally accessed by a child or another member of the household — concerns that some patients and families do think about with take-home film or tablets.
The American Society of Addiction Medicine's National Practice Guideline notes that extended-release injectable buprenorphine carries "no risk for patient diversion or misuse," compared with "some risk" for diversion or misuse associated with daily sublingual film or tablet formulations.
More Consistent Medication Levels
With daily sublingual dosing, buprenorphine levels in your blood naturally rise after you take a dose and gradually decline until the next one — a pattern that repeats every day. Extended-release injections work differently: the medication is released gradually over the course of weeks, which means blood levels stay more even over time, with less of that daily peak-and-trough pattern. ASAM's guideline specifically notes less fluctuation in blood buprenorphine levels with extended-release formulations compared to daily dosing. In practical terms, some patients find that steadier levels translate into more consistent control of cravings and withdrawal symptoms throughout the week, rather than dosing feeling like it "wears off" toward the end of the day.
Privacy and Discretion
For some patients, one of the most appreciated aspects of an injection is simply not having medication in the house or in a bag. There's no film or tablets to carry when you travel, store somewhere secure at home, or explain if someone else happens to come across them. Treatment becomes a scheduled clinic visit — weekly or monthly — rather than a daily at-home ritual. That can be a genuine quality-of-life improvement for people who value discretion or who have found daily dosing to feel like a constant reminder of their diagnosis. This isn't true for everyone, though — some patients actually prefer the routine of daily dosing, and that's a valid preference too.
Who Is a Good Candidate?
Extended-release buprenorphine injections aren't typically a starting point for someone brand new to treatment. Per FDA labeling for both Sublocade and Brixadi, these medications are intended for patients who have already been initiated and stabilized on transmucosal (sublingual) buprenorphine. Your provider will review your treatment history, current dose, and stability before determining whether Sublocade or Brixadi — the two FDA-approved extended-release options — could be an appropriate next step for you.
It's also worth saying plainly: for some people, daily sublingual dosing genuinely remains the better fit, whether for reasons of preference, cost, insurance coverage, or clinical circumstance — and that's completely fine. Choosing between daily dosing and an injection is a shared decision you make together with your provider, not an automatic upgrade that's assumed to be right for everyone.
This article is for general educational purposes and isn't a substitute for individualized medical advice. Your treatment plan should be developed with your own provider based on your specific health history.